Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002425025 | SCV002729506 | uncertain significance | Inborn genetic diseases | 2021-01-21 | criteria provided, single submitter | clinical testing | The p.I3622V variant (also known as c.10864A>G), located in coding exon 59 of the DST gene, results from an A to G substitution at nucleotide position 10864. The isoleucine at codon 3622 is replaced by valine, an amino acid with highly similar properties. This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Clinical Genetics, |
RCV001700573 | SCV001920031 | uncertain significance | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV001700573 | SCV001967243 | uncertain significance | not provided | no assertion criteria provided | clinical testing |